More Business Wire
View Older Stories View Newer Stories-
Arda Therapeutics Secures $43M Series A Financing to Advance Targeted Cell Depletion Therapies
-
FIS Wins Big at the 2024 PayTech Awards USA for Excellence in Payments Technology
-
Putnam Investments Announces 19(a) Notices for Closed-End Funds
-
Vertiv Announces Date of Third Quarter 2024 Earnings Release and Conference Call
-
Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss
-
WisdomTree Prime® Unveils New Earn-Until-You-Spend Functionality with Money Market Fund
-
Globally-Mobile Employees Are Looking for Enhanced Care on Their Assignments
-
Massey Henry Donates $250,000 to Support the Future of Massey Hall
-
Arbo Introduces Project Intelligence Alerts for Commodities Traders and Asset Managers
-
Evercore to Announce Third Quarter 2024 Financial Results and Host Conference Call on October 23, 2024
-
Markel Zubizarreta Joins Kynisca as Global Sporting Director
-
Ryde Launches REMA 2024: A Commitment To Educational Excellence For Driver-Partners’ Children
-
Ontrak Health Collaborates with Major Northeast Regional Plan to Bridge HEDIS Care Gaps Using Ontrak Quality Solution
-
Take-Two Interactive Software, Inc. to Report Second Quarter Fiscal Year 2025 Results on Wednesday, November 6, 2024
-
The Mutual Group Appoints Shannon Woods as General Counsel and Chief Compliance Officer
-
Xevant Unveils New GLP-1 Dashboard to Help Pharmacy Benefit Managers and Consultants Control Rising Therapy Costs with Data-Driven Insights
-
Fastly to Announce Third Quarter 2024 Financial Results
-
Arcus Biosciences to Present First Clinical Data from ARC-20 Study at the 2024 EORTC-NCI-AACR Symposium
-
UserTesting Achieves AWS ISV Accelerate Status, Increasing the Accessibility of its Human Insight Platform and Accelerating Innovation
-
LevelBlue Report Reveals Financial Services Leaders Weigh Trade-Offs Between Innovation and Security
-
Nimbus Therapeutics to Present First Preclinical Data from Werner Syndrome Helicase Program at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
-
Longhorn Vaccines and Diagnostics to Present Data on Universal Influenza Vaccine LHNVD-110 and Antimicrobial Resistant Sepsis Vaccine LHNVD-303 at IDWeek 2024
-
Avanci announces 5G Vehicle license agreement with Toyota
-
MagBio Launches Short Fragment Depletor - 10 High Throughput Kit (SFD-10HT); Bead-based Reagent That Progressively Depletes DNA Fragments <10 kb
-
JPMorgan Chase Commercial Banking and Syracuse University’s D’Aniello IVMF Announce New Cohort of Veteran and Military-Spouse Led Startups for CEOcircle Program
-
New Data Privacy Trends Help Drive Growth in Frequency and Severity of Large Cyber Claims: Allianz
-
Ambulnz by DocGo and Bayhealth Renew Partnership in Delaware, Extending Contract for Three Years
-
GeoPark Announces Third Quarter 2024 Operational Update
-
Ohmium Partners with Lewis County Transit to Launch Washington State's First Zero Emission Transportation Network
-
Bowman Contracted to Provide Support Services for Virginia Department of Transportation Design-Build Projects
-
Organon to Report Third Quarter 2024 Results and Host Conference Call on October 31, 2024
-
Owens Corning to Announce Third-Quarter Financial Results on November 6
-
CIOs Sound Alarm on Network Security as a Top Priority as AI Fuels New Risks and Challenges
-
Metals Acquisition Limited Raises ~A$150 Million (~US$103 Million) Through Successful Placement
-
Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment
-
CareDx Appoints Jing Huang Chief Data and AI Officer
-
InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-488 Meet Primary Endpoint in Psoriasis Patients
-
Ferraro Foods Acquires Botticelli Food Service, Expanding Reach and Strengthening Market Position in the Tri-State Region and Beyond
-
DRIVE Roadside Revolutionizes Roadside Assistance with Free On-Demand Towing App – Available Now!
-
Alnylam Submits Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration for Vutrisiran for the Treatment of Transthyretin Amyloidosis with Cardiomyopathy
-
Marinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual Meeting
-
Audax Private Debt Hires John Wierzba to Lead Wealth Effort
-
Veritone Expands iDEMS Data Integrations to Enhance Public Safety and Law Enforcement Efficiency
-
Amprion Announces Initial Close of a $15M Financing to Commercialize Groundbreaking Neurologic Diagnostics
-
Vizgen and Ultivue Merge to Enable Deeper Insights into Disease Mechanisms and Drive Innovation in Spatial Multi-Omics
-
Sonendo Executes Asset Purchase Agreement to Acquire Biolase Assets
-
MyGuava Partners with QPR to Unveil Exclusive Fan Payment Cards and Exciting Rewards
-
Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024
-
Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4
-
D-Wave Brings Quantum Optimization to 2024 INFORMS Annual Meeting
